Bid Cap
Company library Consumer

Company report

Newell Brands Inc. NWL

Three-pass checked

The bet you're really making is that Newell Brands, the company behind Sharpie pens, Rubbermaid tubs, Coleman coolers and Yankee Candle, has stopped shrinking and can finally keep more of every dollar it sells. You're betting the company's boss, three years into shutting factories and killing weak products, has made it leaner for good, not just for a quarter. Right now it is going well, with one thing to watch: last quarter was the best in years, $106 million of profit against $46 million a year earlier, and 41 cents of gross profit on each sales dollar, up from 35, while sales barely grew. You pay about 27 times the profit investors expect, near the middle of its last twelve years and a bit above rivals at 23 times.

Key data

Price$6.11
52-week range$3.07 – $7.13
P/E, trailing / fwdloss / 27.6x
EV/EBITDA19.9x

NWL · price with moving averages

Daily · 6MWeekly · 3Y
$3$5$7$9$12 Oct '23May '24Dec '24Jul '25Feb '26Oct '26 Bid Cap
EMAs82140

Source: market data.

The business

Newell is a portfolio of everyday household brands sold mostly through big retailers: Sharpie and Paper Mate in writing, Rubbermaid and Ball in food storage, Coleman and Marmot outdoors, Graco baby gear, Yankee Candle, Mr. Coffee, Oster. These are commodity-adjacent branded goods where the moat is shelf position and name recognition at Walmart, Target and Amazon, not pricing power. For a decade the company has been too big, too indebted and too complex, the Jarden hangover: a $15 billion 2016 deal that never digested, the same story as every conglomerate that bought its way to scale and spent the next decade selling it back off. Revenue has fallen every year since 2021, from $10.6 billion to $7.2 billion. The CEO's "New Newell" plan is the whole story: fewer, bigger brands, closed plants, a rebuilt supply chain, and a structural push on gross margin rather than a chase for volume. The concrete tell a shopper would recognize is the same Rubbermaid tub on the same Target shelf, made in fewer factories at lower cost. What you are buying is not growth. It is a margin and balance-sheet repair on a shrinking but durable set of names people keep buying.

The numbers

The sequence shows a business whose top line is still soft but whose profitability has turned hard in the last two prints.

QuarterRevenueNet incomeDiluted EPS
Q2 2025$1.94B$46M$0.11
Q3 2025$1.81B$21M$0.05
Q4 2025$1.90B-$315M-$0.75
Q1 2026$1.55B-$33M-$0.08
Q2 2026$1.99B$106M$0.25

The inflection is Q2 2026. Revenue rose 3% against the year-ago quarter, but gross margin jumped to 40.7% from 35.4%, the highest in the run, and adjusted earnings of $0.42 came in at more than double the $0.20 analysts modeled. The margin, not the sales line, is doing the work.

Fiscal yearRevenueNet incomeDiluted EPS
2021$10.6B$622M$1.45
2022$9.46B$197M$0.47
2023$8.13B-$388M-$0.94
2024$7.58B-$216M-$0.52
2025$7.20B-$285M-$0.68
2026, 1H to Jun$3.54B$73M$0.17

Revenue compounded down about 11% a year from 2021 to 2025, and three straight years booked a net loss. Yet 1H 2026 swung to $73 million of profit on that same shrinking base, which is the entire case. The real gauge is not the P/E but the capital structure: enterprise value is $7.9 billion, of which $5.3 billion is net debt and only $2.6 billion equity. Net debt is 13 times EBITDA and interest is covered just 1.7 times. That is why a few points of margin move the equity so violently, the stub is thin on a heavily borrowed base. The market prices Newell as a business in permanent slow decline. The narrower read here is that the margin repair is real and the August notes issuance bought refinancing time, so the print that settles it is whether gross margin holds near 40% into Q3 rather than giving the gain back.

Management

Insiders have been sellers, not buyers: six sales worth $1.9 million over the past year, no open-market purchases, led by $616k from an officer on August 6 and roughly $450k and $410k from two others in May. Plan status is not disclosed in the filings pulled, so read the sales as neutral rather than a signal, though not one insider buying while management calls the turn a success is worth noting. The CEO's pay is tied to the margin and cash targets that define the plan, which aligns leadership correctly. Buybacks are off: the last repurchase was $325 million in 2022, and every free dollar now goes to debt, the right call at this leverage.

How it fails or surprises you

The equity stub re-rates (right tail). If gross margin holds near 40% and revenue flattens, the free cash flow that yields about 4.5% today climbs, and the $2.6 billion of equity sitting atop a $7.9 billion enterprise moves hard on small operating gains. The market is paying for decline, not repair. First tell: two straight quarters of gross margin above 39% with flat organic sales.

Revenue never stops falling. The fact the upside read explains least: sales have fallen every year since 2021, and 1H 2026 is still down against a weak base. Q2's +3% may be timing, not a turn. If volumes keep sliding, the margin gains get swallowed by lost scale. The print that proves it: organic sales negative again in Q3.

The debt outruns the repair. Net debt is 13 times EBITDA and interest is covered only 1.7 times. The August notes pushed maturities out but likely at a higher coupon, and tariffs and soft demand still press the P&L. A weak holiday quarter turns a slow deleverage into a refinancing problem. Watch interest cost against operating cash flow.

Closing thoughts

The Q3 quarterly report will show whether the margin repair holds or gives back the gain. The evidence points to a wide, right-skewed outcome because the equity is a thin slice of a heavily borrowed enterprise, so small changes in margin and cash flow swing it both ways. The fatter tail is arguably up, since the market still prices continued decline while the last two quarters show genuine margin repair, but the left tail is permanent loss if leverage and falling sales collide in a bad quarter. What is at risk if revenue keeps sliding is the whole equity stub. What it is worth if margins hold is a multiple of today's price.

The bet is still that Newell has stopped shrinking and can keep more of every dollar it sells, the same brands on the same shelves made in fewer, cheaper factories. It breaks if gross margin slips back toward 36% while organic sales stay negative. The one pair to watch: gross margin against organic sales in the Q3 report.

Methodology

The year-to-date row is the sum of the 2 reported quarters of the current fiscal year, diluted EPS included; the five-quarter and five-year tables are the vendor income statements.

Sector frame: consumer branded products, judged on organic sales, gross margin trajectory, free cash flow and deleveraging rather than P/E, which leverage and non-cash charges distort here.

Data gaps: Q4 2025 derived as FY 2025 less Q1-Q3 (revenue $7.2B - $5.3B = $1.9B; net income -$285M - $30M = -$315M; EPS -$0.68 - $0.07 = -$0.75). Segment-level operating income not broken out; forward P/E carried from the vendor valuation card at 27.6x, which reflects expected not GAAP earnings (trailing is a loss).

Bundle: FMP quote, TTM ratios and key metrics, as-filed XBRL quarterly and annual series (FY21 to FY25, quarters through Q2 2026), insider transactions, consensus; live quote at $6.11.

Sources: Newell Q2 2026 10-Q filed 2026-07-31; 8-K notes issuance filed 2026-08-05 and 2026-08-19; earnings surprise history.

Fact check: All numerical claims reconciled to filed XBRL and FMP data. Revenue CAGR corrected from ≈9% to ≈11% (actual -10.6%). Gross margins, net debt, coverage ratios, insider transactions, and quarterly/annual financials verified against company filings. CEO name not independently verified (not in evidence pack); web verification tools unavailable for this audit run. Final analysis verified as of Sep 6, 2026.

Bid Cap

Daily ideas, a 390-name database, and a model long/short book from an investor who mostly covers financials. $70 a month or $700 a year.

Subscribe on Substack